G

    Grifols SA ADR (GRFS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $7.72
    +0.03 (+0.39%)

    Market Cap: $5.23B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    39%(15/38)
    Avg Surprise
    -16.16%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.29
    Range$0.29 - $0.29
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.30+6.6%
    60d ago$0.29+2.9%
    30d ago$0.29+2.9%
    7d ago$0.29+2.9%
    Current$0.29
    Revenue Consensus
    $2.0B
    Range$2.0B - $2.0B
    1 analysts
    Dec 31, 2026
    EPS Consensus$0.47
    Range$0.40 - $0.53
    2 analysts
    Revenue Consensus
    $2.1B
    Range$2.0B - $2.2B
    11 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.47---
    Sep 26EST
    		-$0.29---
    Jun 26
    		$0.19$0.27-29.63%Miss-13.6%
    Mar 26
    		$0.13$0.15-14.97%Miss+35.8%
    Dec 25
    		$0.29$0.29+0.80%Beat+167.4%
    Sep 25
    		$0.21$0.24-12.78%Miss+24.0%
    Jun 25
    		$0.22$0.28-21.43%Miss+46.7%
    Mar 25
    		$0.09$0.16-43.86%Miss+32.0%
    Dec 24
    		$0.11N/A-52.67%Miss-22.8%
    Sep 24
    		$0.17$0.24-29.17%Miss+54.5%
    Jun 24
    		$0.15$0.23-34.78%Miss+50.0%
    Mar 24
    		$0.07N/A-53.33%Miss+59.8%
    Dec 23
    		$0.14$0.22-36.36%Miss+118.4%
    Sep 23
    		$0.11$0.22-50.00%Miss-
    Jun 23
    		$0.10$0.15-33.33%Miss-24.2%
    Mar 23
    		$0.04N/A-72.47%Miss-
    Dec 22
    		$0.06N/A-57.27%Miss-43.5%
    Sep 22
    		$0.00$0.00N/ABeat-100.0%
    Jun 22
    		$0.13N/A-54.84%Miss-52.9%
    Mar 22
    		$0.00$0.00N/ABeat-100.0%
    Dec 21
    		$0.11$0.11+3.09%Beat-60.9%
    Sep 21
    		$0.31$0.31+0.00%Beat-17.0%
    Jun 21
    		$0.28$0.27+3.70%Beat-22.2%
    Mar 21
    		$0.21$0.22-7.39%Miss-13.8%
    Dec 20
    		$0.29$0.25+16.00%Beat-6.5%
    Sep 20
    		$0.37$0.35+5.71%Beat+32.1%
    Jun 20
    		$0.36$0.37-2.70%Miss+9.1%
    Mar 20
    		$0.24$0.30-20.00%Miss-4.0%
    Dec 19
    		$0.31$0.31+0.00%Beat+19.2%
    Sep 19
    		$0.28$0.30-6.67%Miss-3.4%
    Jun 19
    		$0.33$0.32+3.13%Beat-2.9%
    Mar 19
    		$0.25$0.25+0.00%Beat-16.7%
    Dec 18
    		$0.26$0.32-18.75%Miss-10.3%
    Sep 18
    		$0.29$0.31-6.45%Miss+3.6%
    Jun 18
    		$0.34$0.32+6.25%Beat+21.4%
    Mar 18
    		$0.30$0.29+3.45%Beat+11.1%
    Dec 17
    		$0.29$0.31-6.45%Miss+16.0%
    Sep 17
    		$0.28$0.30-6.67%Miss+0.0%
    Jun 17
    		$0.28$0.28+0.00%Beat-
    Mar 17
    		$0.27$0.26+3.85%Beat-
    Dec 16
    		$0.25$0.25+0.00%Beat-
    Sep 16
    		$0.28$0.25+12.00%Beat-

    Dividends

    Dividend Metrics

    Yield3.50%
    Annual/Share$0.27
    Payout Ratio5.04%
    Pay MonthsJul, Aug
    View GRFS's full dividend history

    Key Metrics

    Valuation
    P/E Ratio9.47EV/EBITDA8.16x
    Price/FCF6.26xFCF Yield15.98%
    Profitability
    Profit Margin6.09%Operating Margin15.90%
    ROE6.93%ROIC8.24%
    Financial Health
    Debt/Equity1.35xInterest Coverage2.43x
    Current Ratio2.37xQuick Ratio0.81x
    Trading Statistics
    Beta1.19Avg Volume390.30K
    52-Week High$10.0952-Week Low$6.87

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.92
    SMA 20$7.92
    SMA 50$7.62
    SMA 200$8.21
    EMA 10$7.86
    EMA 20$7.86
    EMA 50$7.77
    EMA 200$8.08

    MACD

    Line: 0.03Signal: 0.08Hist: -0.05

    ADX

    ADX: 18.3+DI: 26.0-DI: 24.6

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down100.0
    PSAR$8.37

    Bollinger Bands

    Upper Band$8.20
    Lower Band$7.64
    %B Position715%(Upper)
    Band Width0.15

    RSI (14-Day)

    Neutral
    46.2

    Momentum Oscillators

    Stoch %K10.3
    Stoch %D21.5
    Williams %R-90.4
    ROC (10d)-0.6%
    Momentum-0.05
    CCI (20d)-147.9
    MFI (14d)24.3

    Volatility Measures

    ATR (14d)$0.20(2.5%)
    StdDev (20d)0.14
    Hist Vol33.2%(Moderate)

    Volume Flow

    VWAP$7.71
    OBV5.5M
    AD Line-411.6M
    CMF (20d)-0.117

    Volume Metrics

    Avg Vol (20d)391.2K
    Vol Ratio1.6x(High)
    VWMA (20d)$7.94

    Pivot Points

    R3$8.03
    R2$7.96
    R1$7.82
    Pivot Point$7.75
    S1$7.62
    S2$7.55
    S3$7.41

    Advanced Oscillators

    TSI3.77
    Ultimate Osc33.9
    KST39.28

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.87B$1.73B$1.96B$1.87B$1.89B$1.79B$1.98B$1.79B$1.82B$1.63B$1.77B$1.60B
    Cost of Revenue$1.17B$1.10B$1.28B$1.11B$1.15B$1.08B$1.21B$1.07B$1.15B$977.30M$1.08B$965.65M
    Gross Profit$704.00M$630.20M$680.40M$751.52M$743.79M$704.64M$766.49M$726.75M$670.44M$648.41M$689.83M$631.83M
    Operating Expenses$375.00M$377.10M$408.17M$368.25M$394.94M$435.78M$394.63M$409.72M$371.12M$444.61M$466.78M$381.24M
    R&D$86.00M$91.48M$135.46M$97.02M$96.19M$96.05M$115.00M$87.88M$90.69M$90.46M$113.58M$87.68M
    SG&A$289.00M$281.00M$155.30M$0$282.76M$325.00M$269.48M$319.43M$299.69M$0$379.55M$300.32M
    Operating Income$329.00M$253.09M$272.23M$383.27M$348.86M$268.86M$371.86M$317.03M$299.32M$203.80M$223.05M$250.59M
    Interest Income$0$0$0$0$9.55M$0$0$0$14.05M$0$0$0
    Interest Expense$80.31M$141.29M$158.49M$156.07M$141.43M$153.59M$15.87M$197.61M$202.51M$169.97M$91.01M$150.94M
    Income Before Tax$247.00M$113.84M$110.05M$198.13M$190.51M$115.27M$210.54M$119.42M$66.98M$47.06M$76.69M$99.59M
    Income Tax Expense$64.00M$24.39M$-14,538,377$54.71M$52.13M$22.84M$126.76M$37.44M$42.21M$24.78M$27.65M$5.58M
    Net Income$154.00M$74.20M$97.33M$126.97M$117.06M$59.73M$68.97M$51.69M$14.84M$21.42M$55.99M$59.54M
    EBITDA$535.00M$360.84M$395.71M$457.05M$347.24M$404.97M$336.54M$468.09M$297.14M$347.53M$334.62M$358.60M
    EBIT$428.00M$255.13M$268.54M$354.20M$331.94M$293.22M$226.41M$359.72M$269.49M$241.91M$226.09M$250.52M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GRFS

    Government Contracts

    Gov Obligations (TTM)
    $1.27M
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    4.5%
    Active Awards
    22
    New Awards (TTM)
    7
    Avg Remaining Term
    2.4 mo

    Top agency: Department of Veterans Affairs at 73.4% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C26026F0037Department of Veterans AffairsDepartment of Veterans Affairs$364000Oct 1, 2025
    36C25526N0141Department of Veterans AffairsDepartment of Veterans Affairs$187878Feb 13, 2026
    36C25626N0079Department of Veterans AffairsDepartment of Veterans Affairs$183367Oct 1, 2025
    36C26026F0015Department of Veterans AffairsDepartment of Veterans Affairs$120000Oct 1, 2025
    36C26026F0019Department of Veterans AffairsDepartment of Veterans Affairs$111000Oct 1, 2025
    36C26026N0067Department of Veterans AffairsDepartment of Veterans Affairs$94176Nov 1, 2025
    36C26326N0209Department of Veterans AffairsDepartment of Veterans Affairs$94081Oct 1, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Grifols stock crosses key 200-day level as investors weigh latest fundamentals

    Grifols stock recently crossed its key 200-day moving average, trading just under $8, signaling a potential shift in investor sentiment. This technical milestone comes as the Spanish plasma specialist focuses on improving profitability, reducing leverage, and experiencing solid demand for its plasma-derived medicines. Investors are closely watching the company's fundamentals, including mid-single-digit revenue growth, improved EBITDA, and declining net debt, to assess its long-term potential.

    Ad-hoc-news.de•8/25/26•
    Bullish

    Grifols (NASDAQ:GRFS) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?

    Grifols (NASDAQ:GRFS) shares briefly crossed above their 200-day moving average of $8.03 before settling at $7.99. Analysts currently hold a "Reduce" rating with a consensus target price of $10.00. The company recently paid a special dividend and saw increased holdings by several hedge funds.

    MarketBeat•8/25/26•
    Neutral

    Grifols, S.A. (GRFS) Investor Outlook: A Potential 35.81% Upside In The Healthcare Sector

    Grifols, S.A. (GRFS), a Spanish healthcare company specializing in plasma-derived medicines, shows significant investment potential with a projected upside of 35.81%. Despite recent challenges, analysts set an average target price of USD 10.87, well above its current USD 8 trading price, supported by a forward P/E ratio of 5.61 and strong free cash flow. The company's diverse business segments, commitment to R&D, and shareholder dividends make it an attractive option for long-term growth investors in the healthcare sector.

    DirectorsTalk Interviews•8/24/26•
    Bullish

    Grifols stock holds steady after Q2 2026 profit jump

    Grifols stock has remained subdued despite reporting higher half-year profit and improved leverage in Q2 2026, with shares down 13.4% year-to-date. Investors are weighing balance-sheet progress against regulatory and operational concerns, including a recent temporary pause in Canadian plasma collections following a donor death. The company continues to invest in clinical programs like the SPARTA Phase 3 study for Prolastin-C and has made board governance adjustments, but the market demands sustained evidence of progress for a re-rating.

    Ad-hoc-news.de•8/22/26•
    Neutral

    Price to earnings forward of Grifols, S.A. Sponsored ADR Class A – LS:A1C3HH

    This article provides financial information for Grifols, S.A. Sponsored ADR Class A under the ticker LS:A1C3HH, specifically focusing on its price to earnings forward ratio. The data is sourced from TradingView and includes market status and an overview of the company's financials. It indicates that the market was closed at the time of publication and no trades were recorded.

    TradingView•8/22/26•
    Neutral

    Frequently Asked Questions About GRFS

    What is GRFS's current dividend yield?
    Grifols SA ADR (GRFS) has a current dividend yield of 3.50%.
    Does GRFS pay dividends?
    Yes, Grifols SA ADR pays dividends with a current yield of 3.50%.
    What is GRFS's P/E ratio?
    Grifols SA ADR has a price-to-earnings (P/E) ratio of 9.47.
    What is GRFS's market cap?
    Grifols SA ADR (GRFS) has a market capitalization of $5.23B with a current stock price of $7.72.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In